The efficacy of dantrolene sodium in controlling exertional rhabdomyolysis in the Thoroughbred racehorse

Equine Veterinary Journal

Volumn 35, Issue 7, 2003, Pages 707-710

  Edwards, J G T ^a,c   Newton, J R ^b   Ramzan, P H L ^a   Pilsworth, R C ^a   Shepherd, M C ^a  

^a BEAUFORT COTTAGE STABLES   (United Kingdom)

^b ANIMAL HEALTH TRUST   (United Kingdom)

^c Fenton Veterinary Practice   (United Kingdom)

Author keywords

Dantrolene sodium; Exertional rhabdomolysis; Horse; Myopathies

Indexed keywords

CREATINE KINASE; DANTROLENE; PLACEBO; CENTRAL MUSCLE RELAXANT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BREEDING; CALCULATION; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFICACY; EXERCISE; HORSE; INCIDENCE; NONHUMAN; RANDOMIZATION; REST; RHABDOMYOLYSIS; TIME; UNITED KINGDOM; WILCOXON SIGNED RANKS TEST; ANIMAL; ANIMAL DISEASE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENZYMOLOGY; FEMALE; HORSE DISEASE; MALE; NONPARAMETRIC TEST; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

ADMINISTRATION, ORAL; ANIMALS; CREATINE KINASE; CROSS-OVER STUDIES; DANTROLENE; DOUBLE-BLIND METHOD; FEMALE; HORSE DISEASES; HORSES; MALE; MUSCLE RELAXANTS, CENTRAL; PHYSICAL CONDITIONING, ANIMAL; RHABDOMYOLYSIS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 1542604275     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516403775696221     Document Type: Article

References (22)

1. Court, M.H., Engelking, L.R., Dodman, N.H., Anwer, M.S., Seeler, D.C. and Clark, M. (1987) Pharmacokinetics of dantrolene sodium in horses. J. vet. Pharmacol. Therap. 10, 218-226.
2. Frauenfelder, H.C., Rossdale, P.D., Ricketts, S.W. and Allen, W.R. (1986) Changes in serum muscle enzyme levels associated with training schedules and stage of the oestrus cycle in Thoroughbred racehorses. Equine vet. J. 18, 371-374.
3. 2+ release by direct and specific action at skeletal muscle ryanodine receptors. J. Biol. Chem. 272, 26965-26971.
4. Harris, P.A. (1991) The equine rhabdomyolysis syndrome in the United Kingdom: epidemiological and clinical descriptive information. Br. vet. J. 147, 373-384.
5. Harris, P.A. (1997) Equine rhabdomyolysis syndrome. In: Current Therapy in Equine Medicine 4, Ed: N.E. Robinson, W.B. Saunders Co., Philadelphia. pp 115-121.
6. Harris, P.A. and Mayhew, I.G. (1998) Musculoskeletal disease. In: Equine Internal Medicine, Eds: S.M. Reed and W.M. Bayly, W.B. Saunders Co., Philadelphia. pp 379-382.
7. Haverkort-Poels, P.J., Joosten, E.M. and Ruitenbeek, W. (1987) Prevention of recurrent exertional rhabdomyolysis by dantrolene sodium. Muscle Nerve 10, 45-46.
8. Hodgson, D.R. (1993) Exercise-associated-myopathy: is calcium the culprit? Equine vet. J. 25, 1-3.
9. Hodgson, D.R. and Rose, R.J. (1994) Recurrent exertional rhabdomyolysis. In: The Athletic Horse: Principles and Practice of Equine Sports Medicine, W.B. Saunders Co., Philadelphia. pp 171-174
10. Jones, W.E. (1989) Exercise intolerance - muscular causes. In: Equine Sports Medicine, Lea and Febiger, Philadelphia. pp 262-267.
11. Lentz, L.R., Valberg, S.J., Balog, E.M., Mickelson, J.R. and Gallant, E.M. (1999) Abnormal regulation of muscle contraction in horses with recurrent exertional rhabdomyolysis. Am. J. vet. Res. 60, 992-999.
12. Lentz, L.R., Valberg, S.J., Herold, L.V., Onan, G.W., Mickelson, J.R. and Gallant, E.M. (2002) Myoplasmic calcium regulation in myotubes from horses with recurrent exertional rhabdomyolysis. Am. J. vet. Res. 63, 1724-1731.
13. 2+ concentration during exertional rhabdomyolysis. Lancet 345, 424-425.
14. Lopez, J.R., Linares, N., Cordovez, G. and Terzic, A. (1995b) Elevated myoplasmic calcium in exercise-induced equine rhabdomyolysis. Pflugers Arch. 430, 293-295.
15. MacLeay, J.M., Sorum, S.A., Valberg, S.J., Marsh, W.E. and Sorum, M.D. (1999) Epidemiologic analysis of factors influencing exertional rhabdomyolysis in thoroughbreds. Am. J. vet. Res. 60, 1562-1566.
16. McGowan, C.M., Fordham, T. and Christley, R.M. (2002) Incidence and risk factors for exertional rhabdomyolysis in thoroughbred racehorses in the United Kingdom. Vet. Rec. 151, 23-626.
17. Rosalki, S.B. (1967) An improved procedure for serum creatinine phosphokinase determination. J. Lab. clin. Med. 69, 696.
18. Valberg, S., Jönsson, L., Lindholm, A. and Holmgren, N. (1993) Muscle histopathology and plasma aspartate aminotransferase, creatine kinase and myoglobin changes with exercise in horses with recurrent exertional rhabdomyolysis. Equine vet. J. 25, 11-16.
19. Valberg, S.J., Mickelson, J.R., Gallant, E.M., MacLeay, J.M., Lentz, L. and De La Corte, F. (1999) Exertional rhabdomyolysis in Quarter Horses and Thoroughbreds: one syndrome, multiple aetiologies. Equine vet. J., Suppl. 30, 533-538.
20. Volfinger, L., Lassourd, V., Michaux, J.M., Braun, J.P. and Toutain, P.L. (1994) Kinetic evaluation of muscle damage during exercise by calculation of amount of creatine kinase released. Am. J. Physiol. 266, 434-441.
21. Ward, A., Chaffman, M.O. and Sorkin, E.M. (1986) Dantrolene: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update on its use in muscle spasicity. Drugs 32, 130-168.
22. Ward, T.L., Valberg, S.J., Gallant, E.M. and Mickelson, J.R. (2000) Calcium regulation by skeletal muscle membranes of horses with recurrent exertional rhabdomyolysis. Am. J. vet. Res. 61, 242-247.